MIR2113

Across TCGA pan-cancer cohorts, MIR2113 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR2113 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR2113 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR2113 expression acts as an unfavorable survival marker.

TGCT, STAD, and ESCA are the cancer types where MIR2113 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.043	0.976	<.001	108	view →
STAD	DFS	Tertile	All	0.176	0.563	<.001	81	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
SARC	DFS	Tertile	All	0.095	0.632	.002	18	view →
LGG	OS	Tertile	All	0.238	0.799	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR2113–TGCT (OS)

Open the TGCT breakdown →